statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agape ATP (NASDAQ:ATPC  Get Free Report) and Better Therapeutics (NASDAQ:BTTX  Get Free Report) are both small-cap medical companies, but which is the better business? We will compare...

Analyzing Better Therapeutics (NASDAQ:BTTX) and Agape ATP (NASDAQ:ATPC)

Titoli in rialzo
Le azioni di Better Therapeutics (NASDAQ:BTTX) hanno guadagnato il 69,14% a 0,06 dollari durante la sessione pre-market di venerd .
Le azioni di Madrigal Pharmaceuticals...

12 titoli sanitari in movimento, pre-market del 15/03/2024

Acciones al alza
Better Therapeutics (NASDAQ:BTTX) ganaron un 77,14% para establecerse en los 0,06 d lares durante la sesi n del pre-market del viernes.
Madrigal Pharmaceuticals (NASDAQ:MDGL...

12 acciones de salud en movimiento durante la preapertura del 15/03/2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Better Therapeutics trading resumes

Better Therapeutics, Inc. (NASDAQ: BTTX) (the Company) announced today that the Company is terminating its employees and will explore strategic alternatives, including assignment for the benefit of...

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

Better Therapeutics trading halted, news pending

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced a major partnership with the American...

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced the acceptance of a late-breaking...

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

ORLANDO, FL / ACCESSWIRE / March 1, 2024 / RedChip Companies will air interviews with Better Therapeutics, Inc. (Nasdaq:BTTX) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big...

Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced that the U.S. Food and Drug...

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.

Volume	238,785.00
52-Wk High	$1.35
52-Wk Low	$0.005

Period	Estimated	Reported	Surprise	Result
Q4'23	-$0.12	--	--	N/A
Q3'23	-$0.20	-$0.15	23.08%	BEAT
Q2'23	-$0.31	-$0.24	23.20%	BEAT
Q1'23	-$0.36	-$0.39	-8.33%	MISSED
Q4'22	-$0.50	-$0.37	26.00%	BEAT

BTTX Better Therapeutics Inc

About

Feed

News

Earnings

Fundamentals